Vitrectomy for Retinal Detachment: Treatment Options & Procedure at MyMedicPlus — Cost, Top Hospitals & Success Rates | MyMedicPlus

Vitrectomy for retinal detachment is a microsurgical procedure performed by vitreoretinal surgeons to repair the separation of the neurosensory retina from its underlying retinal pigment epithelium — a surgical emergency that, without prompt treatment, results in permanent vision loss. Retinal detachment (RD) occurs when fluid accumulates in the subretinal space, typically after a tear or hole in the retina allows liquid vitreous to pass beneath the retina and progressively strip it from the pigment epithelium. The annual incidence is approximately 1 in 10,000 persons, though higher rates are seen in highly myopic individuals, those who have had cataract surgery, and patients with previous retinal detachment in the fellow eye.

Pars plana vitrectomy (PPV) is the primary surgical approach for retinal detachment treatment and has largely supplanted scleral buckling as the predominant technique at most vitreoretinal surgical centres worldwide. The procedure involves making three small sclerotomies (surgical openings) in the sclera at the pars plana region (3.5-4 mm posterior to the limbus) through which the vitreoretinal surgeon introduces a light source, a fragmatome/vitrectomy cutter (which cuts and aspirates the vitreous gel in small fragments), and infusion cannula to maintain intraocular pressure. Using high-magnification viewing systems (wide-field contact or non-contact lenses providing panoramic views of the retina), the surgeon removes the vitreous gel, identifies and treats all retinal breaks (using cryotherapy or endolaser photocoagulation), releases any vitreoretinal traction, and reattaches the retina using either a gas tamponade (perfluoropropane C3F8 or sulphur hexafluoride SF6 gas) or silicone oil to press the retina against the RPE while the laser/cryo adhesions form.

The evolution to small-gauge vitrectomy (25-gauge and 27-gauge systems, compared to the older 20-gauge) has revolutionised the procedure — smaller sclerotomies heal without sutures, surgical time is reduced, post-operative inflammation is minimised, and recovery is significantly faster. Modern vitrectomy machines provide precise cut rates (up to 10,000 cuts per minute), precise infusion control, and improved fluidics that allow safer, more controlled vitreous removal. Advanced visualisation systems including panoramic viewing, intraoperative OCT, and dye-assisted viewing of retinal membranes have further improved surgical outcomes.

Vitrectomy addresses the full spectrum of conditions causing retinal detachment. Rhegmatogenous retinal detachment (RRD) — caused by a retinal break allowing fluid vitreous to enter the subretinal space — is the most common type, typically following posterior vitreous detachment in middle-aged or older adults, and accounts for 85-90% of all retinal detachments. Superior RRDs are particularly time-sensitive as they progress rapidly to involve the macula. Tractional retinal detachment (TRD) occurs in diabetic retinopathy (proliferative diabetic retinopathy — PDR), sickle cell retinopathy, retinopathy of prematurity (ROP), and vitreoretinal scarring from previous inflammation — vitrectomy in these cases involves cutting fibrovascular membranes before retinal reattachment. Exudative (non-rhegmatogenous) retinal detachment requires identifying and treating the underlying cause (tumour, inflammatory disease, hypertensive choroidopathy).

Vitrectomy also treats associated conditions including macular pucker (epiretinal membrane — ERM) causing distorted vision from a fibrous membrane on the macular surface, macular hole (a full-thickness defect in the central macula causing central vision loss), diabetic macular oedema not responding to intravitreal injections, retained lens material or dropped nucleus after complicated cataract surgery, vitreous haemorrhage obscuring the view of the retina, and endophthalmitis (intraocular infection) requiring vitreous sampling and antibiotic injection.

All patients with rhegmatogenous or tractional retinal detachment are candidates for vitrectomy given the alternative is progressive and permanent vision loss. Vitrectomy is the procedure of choice for most retinal detachments, particularly those involving the posterior pole (macula-on or threatening the macula), superior detachments with complex breaks, proliferative vitreoretinopathy (PVR), failed scleral buckling procedures, and detachments associated with a significant vitreous component or large retinal tears. Inferior detachments with simple retinal breaks may be suitable for pneumatic retinopexy (an office-based procedure) as a less invasive alternative in selected patients.

Contraindications to vitrectomy are limited — the severity of the condition (vision loss without treatment) almost always outweighs surgical risks. However, general anaesthetic risk must be assessed for patients requiring general anaesthesia (those unable to cooperate with local anaesthesia). Patients with silicone oil from a previous procedure require careful planning for oil removal or exchange. Patients who cannot adopt the required post-operative positioning (face-down for macular hole, specific posture for gas-tamponaded superior/inferior detachments) due to physical or psychological limitations may be offered modified surgical strategies or silicone oil instead of gas to avoid positioning requirements.

Pars plana vitrectomy (PPV) with gas tamponade (C3F8 or SF6 gas) is the standard technique for most retinal detachments. The choice of tamponade agent depends on the expected reattachment time needed: SF6 gas (absorbs in 10-14 days) for shorter tamponade needs; C3F8 gas (absorbs in 6-8 weeks) for complex detachments requiring longer tamponade. Silicone oil tamponade is used for the most complex cases — inferior retinal detachments requiring patient positioning that gas cannot achieve, patients who cannot maintain face-down positioning, very advanced PVR, and patients with only one eye.

Combined phacoemulsification cataract surgery and PPV ('phacovitrectomy') is performed in phakic patients over 50 years, removing the crystalline lens simultaneously to improve surgical access to the peripheral retina, avoid post-operative cataract formation (universal with gas-filled vitreous), and improve surgical outcomes. Pneumatic retinopexy — injection of gas into the vitreous cavity in the clinic under local anaesthesia without formal vitrectomy, combined with cryotherapy or laser — is a minimally invasive outpatient alternative for simple superior RRDs with single breaks in the superior 8 clock hours, achieving primary success in 70-80% of selected cases. Scleral buckling (external silicone explant sutured to the sclera) remains the preferred technique at some centres for younger phakic patients with simple peripheral detachments, as it avoids cataract formation and preserves accommodative ability.

Vitrectomy for retinal detachment achieves primary anatomical reattachment in 85-95% of cases in the hands of experienced vitreoretinal surgeons, with secondary success rates (after one or more re-operations) exceeding 98%. Visual outcomes are most strongly predicted by macular status at time of surgery: in macula-on retinal detachments (where the central vision-determining macular region remains attached), over 90% of patients retain 20/40 or better vision after successful reattachment, making prompt surgery essential. In macula-off detachments (where the macula has been detached for more than 24-48 hours), visual recovery is variable — approximately 50-70% achieve 20/40 or better vision, but outcomes deteriorate with longer pre-operative macular detachment duration.

Macular hole surgery with vitrectomy achieves anatomical closure in 90-95% of cases, with visual improvement in 70-80% of patients. Epiretinal membrane peeling produces significant vision improvement and symptom relief in over 80% of patients. For tractional retinal detachment from diabetic retinopathy, vitrectomy prevents complete retinal detachment, stabilises or improves vision, and may be combined with panretinal photocoagulation to address the underlying neovascular drive. Long-term reattachment durability is high — over 90% of successfully reattached retinas remain attached at 10 years in the absence of new retinal breaks.

Cataract development is the most common complication of vitrectomy in phakic patients, occurring in 80% within 2 years as gas tamponade and surgical manipulation accelerate lens opacification. This is predictable and manageable with subsequent cataract surgery. Raised intraocular pressure (IOP) in the early post-operative period can occur from gas expansion if the patient travels by air or moves to high altitude (strict air travel restriction while gas is present), from silicone oil migration, or from inflammatory response. Intraocular pressure monitoring is essential post-operatively.

Proliferative vitreoretinopathy (PVR) — fibrocellular proliferation on the retinal surface causing re-detachment — is the most significant cause of surgical failure, occurring in 5-10% of cases and typically requiring complex revision vitrectomy with silicone oil. Endophthalmitis (intraocular infection) is a rare but devastating complication (0.03-0.05% incidence) that requires urgent re-operation and intravitreal antibiotics. Choroidal haemorrhage, retinal haemorrhage, macular pucker as a post-operative complication, and persistent vitreous haemorrhage are additional procedure-related risks. Silicone oil complications include emulsification and intraocular dispersion, IOP elevation, and band keratopathy, requiring eventual silicone oil removal surgery.

Post-vitrectomy follow-up is intensive in the early period: day 1, day 3-5, 2 weeks, 4-6 weeks, and then 3-monthly until the gas or silicone oil is managed. Patients with gas tamponade have strict activity restrictions: face-down positioning (for macular hole, for inferior retinal breaks) for 2-5 days; no air travel until gas has fully absorbed (may take 6-8 weeks for C3F8); no nitrous oxide anaesthesia for any procedure while gas is present (risk of gas expansion and acute vision-threatening IOP rise). Visual acuity typically improves progressively as gas absorbs, with significant improvement apparent by 6-8 weeks.

For silicone oil tamponade, oil removal surgery is typically planned 3-6 months after the retinal detachment repair once stable reattachment is confirmed. Silicone oil remaining for extended periods carries risks of oil-related complications (see risks section). Patients are instructed to return immediately (same day or emergency department) if they experience sudden worsening of vision, new floaters, curtain effect, or pain — symptoms that may indicate re-detachment requiring urgent surgical re-intervention. Post-operative topical antibiotic and steroid eye drops are prescribed for 4-6 weeks to prevent infection and manage inflammation.

Retinal detachment surgery is an ophthalmic emergency and is covered by health insurance and national health systems in most countries. In the UK, NHS emergency vitrectomy is performed promptly and free of charge. In the USA, vitrectomy for retinal detachment costs USD 8,000-20,000 at private rates, covered by most major health insurances as a medically necessary procedure. Elective vitrectomy for macular hole or epiretinal membrane in the UK under private care costs GBP 3,000-6,000; in the USA USD 7,000-15,000.

For international patients without insurance coverage, or for elective vitreoretinal procedures, medical travel offers substantial savings. India has world-class vitreoretinal surgery expertise — institutions such as Sankara Nethralaya (Chennai), L V Prasad Eye Institute (Hyderabad), Aravind Eye Care System, and major tertiary hospital ophthalmology departments perform thousands of vitreoretinal surgeries annually with outcomes comparable to the best Western centres. Vitrectomy for retinal detachment at these institutions costs USD 1,500-5,000 all-inclusive. Thailand (Rutnin Eye Hospital, Bangkok) offers vitrectomy at USD 3,000-6,000 with internationally trained vitreoretinal surgeons. For non-emergency elective procedures (macular hole, ERM), India and Thailand provide excellent value.

Pneumatic retinopexy is a clinic-based alternative for simple superior rhegmatogenous retinal detachments (single break in superior 8 clock hours, no significant PVR): a gas bubble is injected into the vitreous cavity without formal vitrectomy, combined with cryotherapy or laser to seal the break. Success rate is 70-80% for properly selected cases — lower than vitrectomy but offering no formal surgery, faster recovery, and preservation of the crystalline lens. Failed pneumatic retinopexy is salvaged with vitrectomy.

Scleral buckling (implanting an external silicone band around the sclera to indent the eye wall and close retinal breaks) is the historical standard for rhegmatogenous RD and remains preferred at some centres for younger myopic patients with peripheral simple detachments, as it avoids the vitreous cavity altogether and does not accelerate cataract formation. A meta-analysis suggests comparable long-term outcomes between scleral buckling and PPV for primary RRD without macular detachment in phakic patients. The choice between vitrectomy, scleral buckling, and pneumatic retinopexy is made by the vitreoretinal surgeon based on break characteristics, macular status, patient age, and lens status.